Question

OmniChem Corporation applies for a patent for a certain chemical compound. Meanwhile, OmniChem licenses its products, including the compound, to Pharmo, Inc., which uses the compound to make an anti-cancer prescription drug. Under the terms of the license, Pharmo agrees to pay royalties on OmniChem's "patented" products. When a patent is granted on the compound, OmniChem asks Pharmo to pay royalties on the sales of the anti-cancer drug or stop selling it. Pharmo files a challenge to the validity of OmniChem's patent. Both firms assert their claims less from an interest in profit than a belief in the "rightness" of their respective causes. This position might arguably be
A.illegal.
B.optimal.
C.socially irresponsible.
D.unethical.

Answer

This answer is hidden. It contains 2 characters.